Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 23, 2020

SELL
$1.91 - $3.08 $1.66 Million - $2.68 Million
-870,600 Closed
0 $0
Q2 2020

Jul 16, 2020

BUY
$1.97 - $3.98 $261,517 - $528,345
132,750 Added 17.99%
870,600 $2.4 Million
Q1 2020

Apr 23, 2020

BUY
$1.17 - $3.0 $288,697 - $740,250
246,750 Added 50.24%
737,850 $2.21 Million
Q4 2019

Feb 05, 2020

BUY
$1.16 - $1.42 $66,990 - $82,005
57,750 Added 13.33%
491,100 $653,000
Q3 2019

Oct 18, 2019

BUY
$1.21 - $1.65 $27,104 - $36,960
22,400 Added 5.45%
433,350 $579,000
Q2 2019

Aug 01, 2019

BUY
$1.39 - $2.03 $97,161 - $141,897
69,900 Added 20.5%
410,950 $685,000
Q1 2019

May 15, 2019

BUY
$1.39 - $1.71 $474,059 - $583,195
341,050 New
341,050 $526,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.